Technical Note: Enhancing 3D Cancer Spheroid Models with Innovative Synthetic Hydrogel
Authors: Daryl Cole, Natasha Lewis, and Kalpana Barnes | Last updated: May 2025
Overview
This technical note investigates the transformative potential of NexaGel®*, a synthetic hydrogel that is redefining the landscape of cancer spheroid assays. As researchers strive for more accurate models of tumor biology, NexaGel® emerges as a superior alternative to traditional animal-derived matrices.
Cancer spheroids offer a more realistic representation of tumor biology compared to conventional two-dimensional cell cultures. They mimic the complex cellular interactions and microenvironment found in actual tumors, providing invaluable insights into cancer behavior and treatment responses.
Our technical note highlights the use of NexaGel® in cancer spheroid assays, showcasing its ability to support the formation of spheroids with MCF7 and A549 cell lines. NexaGel® facilitates distinct growth dynamics and morphologies, necessitating careful optimization of experimental parameters such as cell seeding densities for optimal results.
Explore the full technical note to discover how NexaGel® is paving the way for more accurate and effective cancer research. Whether you're focused on developing new therapeutic strategies or expanding into other areas of biomedical research, NexaGel® offers the versatility and precision needed to drive innovation.
- Document type: Technical note
- Page count: 8
- Read time: 10 Minutes
Key Takeaways
- Enhanced Tumor Modeling: Cancer spheroids, supported by NexaGel®, provide a more accurate representation of tumor biology compared to traditional 2D cultures, mimicking in vivo conditions such as hypoxia and nutrient gradients.
- Synthetic Hydrogel Advantages: NexaGel® offers a reproducible and tunable environment for spheroid formation, overcoming limitations of animal-derived matrices including batch variability and undefined composition.
- Optimized Experimental Parameters: The distinct growth dynamics and morphologies observed in spheroids formed with NexaGel® necessitate careful optimization of experimental parameters, such as cell seeding densities, to achieve desired outcomes.
- Versatility Across Research Fields: Beyond cancer studies, NexaGel®'s synthetic matrix is applicable in toxicology, regenerative medicine, and large-scale cell studies, providing new opportunities for exploration and innovation in biomedical research.
- Ethical and Clinical Benefits: The use of synthetic matrices like NexaGel® supports ethical research practices and enhances the potential for clinically translational models, paving the way for more effective therapeutic strategies and personalized medicine approaches.
Complete The Form to Access the Technical Note
*NexaGel® is a registered trademark of Sartorius Bioanalytical Instruments, Inc. For details on registrations, please refer to our website https://www.sartorius.com/en/patents-and-trademarks